Morton's Neuroma: Manipulation Versus Steroid Injection

Sponsor
Dundee Podiatry Clinic (Other)
Overall Status
Completed
CT.gov ID
NCT05707572
Collaborator
Queen Margaret University (Other)
62
1
2
60.9
1

Study Details

Study Description

Brief Summary

This study compares manipulative therapy to steroid injection in the treatment of Morton's Neuroma.

Condition or Disease Intervention/Treatment Phase
N/A

Detailed Description

The aim of this study is to establish whether manipulative therapy is an effective treatment for Morton's neuroma, a nerve entrapment in the foot. Steroid injection is the current gold standard conservative treatment for this condition. Therefore, a subject group shall be compared to a steroid injection intervention group. Outcomes will be compared using visual analogue pain scales -VAS, Foot Function Index questionnaires and algometric pressure threshold testing. An improvement in the manipulation group VAS of 20mm above the injection group shall be considered as the minimum worthwhile change as this has been identified as the minimum clinically important difference in pain between treatment groups in visual analogue pain scales.

Study Design

Study Type:
Interventional
Actual Enrollment :
62 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Manipulation Versus Steroid Injection in the Treatment of Morton's Neuroma
Actual Study Start Date :
Sep 1, 2014
Actual Primary Completion Date :
Sep 1, 2018
Actual Study Completion Date :
Sep 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: steroid injection

1 injection of 1mL methylprednisolone [40mg]with 1 mL 2% lignocaine

Drug: methylprednisolone
a single injection of 1 mL methylprednisolone [40 mg] and 1 mL 2% lignocaine
Other Names:
  • Depo-Medrone with Lidocaine (40mg + 10mg)/ml
  • Experimental: manual manipulation

    weekly manipulations to the metatarsophalangeal joints of the forefoot for 6 weeks

    Procedure: manual manipulation
    The lesser MTPJs of the affected foot will be manually manipulated using a high velocity, low amplitude thrust technique.
    Other Names:
  • adjustment
  • Outcome Measures

    Primary Outcome Measures

    1. Visual analogue pain scale [pre treatment at each clinic visit and then 3,6,9 and 12 months]

      Measuring changes in self reported pain over time. 100mm scale with anchored prompts of "no pain" at 0mm and "worst pain ever" at 100mm

    Secondary Outcome Measures

    1. Algometric pressure threshold meter [pre treatment at each clinic visit and then 3,6,9 and 12 months]

      Measuring changes in pressure tolerance over time. A meter which reads how much change in pressure a joint can withstand before it registers discomfort

    Other Outcome Measures

    1. Foot function index questionnaire [pre treatment at each clinic visit and then 3,6,9 and 12 months]

      A questionnaire to establish subjects level of function, pain and mobility changes over time

    2. Manchester Oxford Foot Pain Questionnaire [pre treatment at each clinic visit and then 3,6,9 and 12 months]

      Patient reported outcome measurement tool to measure changes in foot pain over time

    3. Short Form 36 pain and disability Questionnaire [pre treatment at each clinic visit and then 3,6,9 and 12 months]

      A quality of life questionnaire

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • clinical diagnosis of morton's neuroma

    • over 18 years of age

    • presenting VAS score > 30mm

    Exclusion Criteria:
    • diabetes,

    • rheumatoid arthritis

    • fibromyalgia.

    • Those currently taking Statins or analgesics

    • previous neuroma surgery

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Podiatry Department NHS Lothian Edinburgh Lothian United Kingdom EH3 9AU

    Sponsors and Collaborators

    • Dundee Podiatry Clinic
    • Queen Margaret University

    Investigators

    • Principal Investigator: David G Cashley, BSc(Hons)Pod, Queen Margaret University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Dundee Podiatry Clinic
    ClinicalTrials.gov Identifier:
    NCT05707572
    Other Study ID Numbers:
    • PDN001
    • 129586
    First Posted:
    Feb 1, 2023
    Last Update Posted:
    Feb 1, 2023
    Last Verified:
    Jan 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Dundee Podiatry Clinic
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 1, 2023